Invesco’s Mesa Laboratories MLAB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $1.25M | Buy |
14,103
+1,258
| +10% | +$108K | ﹤0.01% | 2764 |
|
|
2025
Q4 | $1.01M | Buy |
12,845
+1,350
| +12% | +$103K | ﹤0.01% | 2907 |
|
|
2025
Q3 | $770K | Sell |
11,495
-6,300
| -35% | -$453K | ﹤0.01% | 3046 |
|
|
2025
Q2 | $1.68M | Sell |
17,795
-134
| -0.7% | -$14.7K | ﹤0.01% | 2636 |
|
|
2025
Q1 | $2.13M | Sell |
17,929
-578
| -3% | -$78.8K | ﹤0.01% | 2517 |
|
|
2024
Q4 | $2.44M | Buy |
18,507
+69
| +0.4% | +$8.47K | ﹤0.01% | 2537 |
|
|
2024
Q3 | $2.39M | Sell |
18,438
-1,361
| -7% | -$160K | ﹤0.01% | 2533 |
|
|
2024
Q2 | $1.72M | Sell |
19,799
-1,278
| -6% | -$134K | ﹤0.01% | 2654 |
|
|
2024
Q1 | $2.31M | Buy |
21,077
+2,231
| +12% | +$225K | ﹤0.01% | 2590 |
|
|
2023
Q4 | $1.97M | Sell |
18,846
-2,835
| -13% | -$276K | ﹤0.01% | 2618 |
|
|
2023
Q3 | $2.28M | Buy |
21,681
+96
| +0.4% | +$12.3K | ﹤0.01% | 2553 |
|
|
2023
Q2 | $2.77M | Sell |
21,585
-209,424
| -91% | -$31.9M | ﹤0.01% | 2524 |
|
|
2023
Q1 | $40.4M | Sell |
231,009
-1,418
| -0.6% | -$254K | 0.01% | 1042 |
|
|
2022
Q4 | $38.6M | Buy |
232,427
+801
| +0.3% | +$126K | 0.01% | 1033 |
|
|
2022
Q3 | $32.6M | Sell |
231,626
-44,895
| -16% | -$8.19M | 0.01% | 1079 |
|
|
2022
Q2 | $56.4M | Sell |
276,521
-1,029
| -0.4% | -$225K | 0.02% | 886 |
|
|
2022
Q1 | $70.7M | Buy |
277,550
+1,898
| +0.7% | +$515K | 0.02% | 886 |
|
|
2021
Q4 | $90.4M | Buy |
275,652
+26,821
| +11% | +$8.42M | 0.02% | 844 |
|
|
2021
Q3 | $75.2M | Sell |
248,831
-9,585
| -4% | -$2.72M | 0.02% | 897 |
|
|
2021
Q2 | $70.1M | Sell |
258,416
-7,367
| -3% | -$1.87M | 0.02% | 946 |
|
|
2021
Q1 | $64.7M | Sell |
265,783
-40
| -0% | -$11K | 0.02% | 954 |
|
|
2020
Q4 | $76.2M | Sell |
265,823
-9,967
| -4% | -$2.74M | 0.02% | 861 |
|
|
2020
Q3 | $70.3M | Buy |
275,790
+50,990
| +23% | +$12.1M | 0.02% | 787 |
|
|
2020
Q2 | $48.7M | Sell |
224,800
-10,461
| -4% | -$2.41M | 0.02% | 918 |
|
|
2020
Q1 | $53.2M | Buy |
235,261
+210,383
| +846% | +$51.9M | 0.02% | 772 |
|
|
2019
Q4 | $6.21M | Sell |
24,878
-6,434
| -21% | -$1.51M | ﹤0.01% | 2033 |
|
|
2019
Q3 | $7.45M | Buy |
31,312
+3,283
| +12% | +$759K | ﹤0.01% | 1890 |
|
|
2019
Q2 | $6.85M | Buy |
28,029
+23,813
| +565% | +$5.55M | ﹤0.01% | 1994 |
|
|
2019
Q1 | $972K | Sell |
4,216
-4,920
| -54% | -$1.11M | ﹤0.01% | 3034 |
|
|
2018
Q4 | $1.9M | Buy |
9,136
+4,221
| +86% | +$823K | ﹤0.01% | 2572 |
|
|
2018
Q3 | $913K | Buy |
4,915
+1,251
| +34% | +$252K | ﹤0.01% | 3179 |
|
|
2018
Q2 | $773K | Buy |
3,664
+907
| +33% | +$159K | ﹤0.01% | 3253 |
|
|
2018
Q1 | $409K | Buy |
+2,757
| New | +$376K | ﹤0.01% | 3409 |
|
|
2017
Q4 | – | Sell |
-7,531
| Closed | -$1.13M | – | 3655 |
|
|
2017
Q3 | $1.13M | Buy |
7,531
+48
| +0.6% | +$6.77K | ﹤0.01% | 2939 |
|
|
2017
Q2 | $1.07M | Sell |
7,483
-1,657
| -18% | -$236K | ﹤0.01% | 2971 |
|
|
2017
Q1 | $1.12M | Buy |
+9,140
| New | +$1.12M | ﹤0.01% | 2982 |
|
|
2016
Q4 | – | Sell |
-8,563
| Closed | -$979K | – | 3696 |
|
|
2016
Q3 | $979K | Buy |
+8,563
| New | +$976K | ﹤0.01% | 2961 |
|
|
2016
Q2 | – | Sell |
-8,058
| Closed | -$776K | – | 3703 |
|
|
2016
Q1 | $776K | Buy |
+8,058
| New | +$726K | ﹤0.01% | 3039 |
|
|
2015
Q3 | – | Sell |
-268
| Closed | -$24K | – | 3911 |
|
|
2015
Q2 | $24K | Buy |
268
+80
| +43% | +$6.76K | ﹤0.01% | 4030 |
|
|
2015
Q1 | $14K | Sell |
188
-32
| -15% | -$2.38K | ﹤0.01% | 3948 |
|
|
2014
Q4 | $17K | Sell |
220
-2
| -0.9% | -$146 | ﹤0.01% | 3961 |
|
|
2014
Q3 | $13K | Sell |
222
-21,556
| -99% | -$1.56M | ﹤0.01% | 4010 |
|
|
2014
Q2 | $1.83M | Sell |
21,778
-5,396
| -20% | -$446K | ﹤0.01% | 2641 |
|
|
2014
Q1 | $2.45M | Buy |
+27,174
| New | +$2.31M | ﹤0.01% | 2430 |
|
Other funds holding MLAB
LPP
VCM
RIM
RA
Invesco's MLAB Position: Q1 2026 in Review
Invesco increased its Mesa Laboratories (MLAB) stake by 9.8% in Q1 2026, buying an estimated $108K and bringing the position to 14,103 shares worth $1.25M. The position accounts for ﹤0.01% of the portfolio, ranked #2764.
Invesco first reported a position in MLAB in Q1 2014 and has held it in 44 quarters since. The position peaked at $90.4M in Q4 2021. 161 funds tracked by Wall St. Rank hold MLAB as of Q1 2026.
- Invesco held 14,103 shares of Mesa Laboratories worth $1.25M as of Q1 2026.
- Invesco bought 1,258 Mesa Laboratories shares in Q1 2026, an estimated $108K.
- Mesa Laboratories made up ﹤0.01% of Invesco's portfolio in Q1 2026, its #2764 holding.
- Invesco first reported a position in Mesa Laboratories in Q1 2014 and has held it in 44 quarters since.
- Invesco's Mesa Laboratories position peaked at $90.4M in Q4 2021.
- 161 funds tracked by Wall St. Rank held Mesa Laboratories as of Q1 2026.
Based on Invesco's 13F filing for Q1 2026, filed 12 May 2026.